Page 2 - Bmy Exclusive Interview News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bmy exclusive interview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bmy Exclusive Interview Today - Breaking & Trending Today

Metis Global Partners LLC Increases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Metis Global Partners LLC grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 17.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 119,251 shares of the biopharmaceutical company’s stock after buying an additional 17,479 shares during […] ....

Turtle Creek , United States , Blue Bell , Bristol Myers Squibb , William Blair , Pomalyst Imnovid , Bristol Myers Squibb Company , Wells Fargo Company , Wetzel Investment Advisors Inc , Metis Global Partners , Securities Exchange Commission , Milestone Investment Advisors , Bristol Myers Squibb Company Profile , Blue Bell Private Wealth Management , Turtle Creek Wealth Advisors , Free Report , Global Partners , Asset Management , Investment Advisors , Bell Private Wealth Management , Creek Wealth Advisors , Wetzel Investment Advisors , Myers Squibb , Get Free Report , Myers Squibb Company , Visit Holdingschannel ,

Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Squibb Co. (BMY) announced Monday that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC). ....

European Medicines Agency , Bristol Myers Squibb Co , Bristol Myers Squibb , Blinded Independent Clinical Review , Metastatic Colorectal Cancer , Bristol Myers Squibb , Ervoy , Heckmate 8hw Study ,

Gallacher Capital Management LLC Has $403,000 Holdings in Bristol-Myers Squibb (NYSE:BMY)

Gallacher Capital Management LLC increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 57.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,857 shares of the biopharmaceutical company’s stock after purchasing an additional 2,855 shares during the quarter. Gallacher Capital […] ....

United States , Societe Generale , William Blair , Redburn Atlantic , Pomalyst Imnovid , Bristol Myers Squibb , Mcclarren Financial Advisors Inc , Kestra Private Wealth Services , Metis Global Partners , Exchange Commission , Gallacher Capital Management , Bristol Myers Squibb Company , Bristol Myers Squibb Company Profile , Institute For Wealth Management , Herold Advisors Inc , Free Report , Capital Management , Clarren Financial Advisors , Wealth Management , Private Wealth Services , Global Partners , Myers Squibb , Get Free Report , Myers Squibb Company , Bristol Myers Squibb Daily , Nyse Bmy ,

ARS Wealth Advisors Group LLC Has $421,000 Stake in Bristol-Myers Squibb (NYSE:BMY)

ARS Wealth Advisors Group LLC trimmed its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 92.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,199 shares of the biopharmaceutical company’s stock after selling 103,371 shares during the period. ARS […] ....

United States , William Blair , Societe Generale , Pomalyst Imnovid , Redburn Atlantic , Bristol Myers Squibb , Wealth Advisors Group , Northern Trust Corp , Australiansuper Pty Ltd , Ars Wealth Advisors Group , Pacer Advisors Inc , Wells Fargo Company , Associates Corp , Mizuho Markets Americas , Exchange Commission , Bristol Myers Squibb Company , Free Report , Advisors Group , Super Pty Ltd , Markets Americas , Trust Corp , Myers Squibb , Get Free Report , Wells Fargo , Myers Squibb Company , Visit Holdingschannel ,

First Horizon Advisors Inc. Increases Stake in Bristol-Myers Squibb (NYSE:BMY)

First Horizon Advisors Inc. increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 93,408 shares of the biopharmaceutical company’s stock after buying an additional 2,075 shares during […] ....

Blue Bell , United States , Turtle Creek , Societe Generale , Redburn Atlantic , Bristol Myers Squibb , William Blair , Pomalyst Imnovid , Wells Fargo Company , Milestone Investment Advisors , Securities Exchange Commission , Blue Bell Private Wealth Management , Bristol Myers Squibb Company , Turtle Creek Wealth Advisors , First Horizon Advisors Inc , Legacy Financial Group , First Horizon Advisors , Free Report , Horizon Advisors , Asset Management , Investment Advisors , Bell Private Wealth Management , Financial Group , Myers Squibb , Get Free Report , Myers Squibb Company ,